On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Patients with triple-negative breast cancer have a poor outcome owing to the clinically aggressive behavior of the disease and the lack of hormonal or targeted therapies. Identification of new actionable targets to guide the development of effective treatments remains a critical clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudghene-Stambouli, Fadia, Soulez, Mathilde, Ronkina, Natalia, Dörrie, Anneke, Kotlyarov, Alexey, Seternes, Ole-Morten, Gaestel, Matthias, Meloche, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817496/
https://www.ncbi.nlm.nih.gov/pubmed/36612022
http://dx.doi.org/10.3390/cancers15010025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817496/
https://www.ncbi.nlm.nih.gov/pubmed/36612022
http://dx.doi.org/10.3390/cancers15010025

Ejemplares similares